MedTrace Logo

Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients

NCT05070494 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2021-11-03

No results posted yet for this study

Summary

This study was a randomized controlled trial to investigate the immune response of influenza vaccines when doses were increased. and a second vaccination together with an increase in the amount of vaccine in patients with chronic kidney disease receiving hemodialysis

Conditions

  • ESRD
  • Influenza Vaccine
  • Seroprotection

Interventions

BIOLOGICAL

Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)

study of immunologic response to different dose and duration of Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)

Sponsors & Collaborators

  • Bhumirajanagarindra Kidney Institute, Thailand

    collaborator OTHER

  • Ministry of Health, Thailand

    collaborator OTHER_GOV

  • Mahidol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-04-01
Completion
2022-12-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070494 on ClinicalTrials.gov